[go: up one dir, main page]

WO2002029049A3 - Regulation of human sodium-dependent monoamine transporter - Google Patents

Regulation of human sodium-dependent monoamine transporter Download PDF

Info

Publication number
WO2002029049A3
WO2002029049A3 PCT/EP2001/011441 EP0111441W WO0229049A3 WO 2002029049 A3 WO2002029049 A3 WO 2002029049A3 EP 0111441 W EP0111441 W EP 0111441W WO 0229049 A3 WO0229049 A3 WO 0229049A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoamine transporter
human sodium
regulation
dependent monoamine
dependent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011441
Other languages
French (fr)
Other versions
WO2002029049A2 (en
Inventor
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2001293863A priority Critical patent/AU2001293863A1/en
Publication of WO2002029049A2 publication Critical patent/WO2002029049A2/en
Publication of WO2002029049A3 publication Critical patent/WO2002029049A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Reagents which regulate human sodium-dependent monoamine transporter and reagents which bind to human sodium-dependent monoamine transporter gene products can play a role in preventing, ameliorating, or correcting CNS dysfunctions or diseases.
PCT/EP2001/011441 2000-10-05 2001-10-04 Regulation of human sodium-dependent monoamine transporter Ceased WO2002029049A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001293863A AU2001293863A1 (en) 2000-10-05 2001-10-04 Regulation of human sodium-dependent monoamine transporter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23768100P 2000-10-05 2000-10-05
US60/237,681 2000-10-05

Publications (2)

Publication Number Publication Date
WO2002029049A2 WO2002029049A2 (en) 2002-04-11
WO2002029049A3 true WO2002029049A3 (en) 2002-11-28

Family

ID=22894719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011441 Ceased WO2002029049A2 (en) 2000-10-05 2001-10-04 Regulation of human sodium-dependent monoamine transporter

Country Status (2)

Country Link
AU (1) AU2001293863A1 (en)
WO (1) WO2002029049A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8141601B2 (en) 2008-10-02 2012-03-27 Roche Diagnostics Operations, Inc. Manual filling aid with push button fill

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031539A1 (en) * 1994-05-16 1995-11-23 Human Genome Sciences, Inc. Neurotransmitter transporter
WO2001057276A2 (en) * 2000-02-04 2001-08-09 Aeomica, Inc. Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031539A1 (en) * 1994-05-16 1995-11-23 Human Genome Sciences, Inc. Neurotransmitter transporter
WO2001057276A2 (en) * 2000-02-04 2001-08-09 Aeomica, Inc. Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, HINXTON, UK; 1 May 2000 (2000-05-01), "Homo sapiens chromosome 19 clone CTC-301O7, complete sequence.", XP002210702, Database accession no. AC011450 *
DATABASE GENSEQ [online] Derwent; 13 February 2002 (2002-02-13), "Novel human diagnostic protein #16774.", XP002210704, Database accession no. ABG16783 *
DATABASE GENSEQ [online] Derwent; 13 February 2002 (2002-02-13), DRMANAC ET AL.: "DNA encoding novel human diagnostic protein #16774.", XP002210703, Database accession no. AAS80970 *
DATABASE GENSEQ [online] Derwent; 6 November 2001 (2001-11-06), PENN ET AL.: "Human bone marrow expressed single exon probe SEQ ID NO: 12101.", XP002210705, Database accession no. AAK37544 *

Also Published As

Publication number Publication date
AU2001293863A1 (en) 2002-04-15
WO2002029049A2 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
WO2002036783A3 (en) Regulation of human histone deacetylase
WO2002030970A3 (en) Human histone deacetylase gene
WO2002070675A3 (en) Regulation of human histone acetyltransferase
WO2002020731A3 (en) Regulation of human protein disulfide isomerase-like enzyme
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2002029049A3 (en) Regulation of human sodium-dependent monoamine transporter
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002048325A3 (en) Regulation of human serine palmitoyltransferase
WO2002081705A3 (en) Regulation of human gnat acetyltransferase-like protein
WO2002088362A3 (en) Regulation of human prostaglandin-f synthase 1-like protein
WO2002033080A3 (en) Regulation of human netrin binding membrane receptor unc5h-1
WO2002055712A3 (en) Regulation of human alanine aminotransferase
WO2002048358A3 (en) Regulation of human chemokine-like receptor
WO2002033097A3 (en) Regulation of human sulfotransferase
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2002036781A3 (en) Regulation of human glutathione-s-transferase
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2002053756A3 (en) Regulation of human glucosamine-6-phosphate deaminase
WO2002052020A3 (en) Regulation of human carboxypeptidase a
WO2002057461A3 (en) Regulation of human adam-ts-like zinc metalloprotease
WO2002051996A3 (en) Regulation of human cyclophilin-like protein
WO2002072825A3 (en) Human mrp5-like protein
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002024731A3 (en) Regulation of human fgd1-like protein
WO2002029048A3 (en) Regulation of human sodium-dependent neurotransmitter transporter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10398119

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP